Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Maurizio Cabibbe

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Frontiers in Microbiology|February 23, 2023
Advantages of long- and short-reads sequencing for the hybrid investigation of the <i>Mycobacterium tuberculosis</i> genomeFederico Di Marco, Andrea Spitaleri, Simone Battaglia, et al.
Journal of Clinical Microbiology|September 6, 2024
Nanopore-based targeted sequencing test for direct tuberculosis identification, genotyping, and detection of drug resistance mutations: a side-by-side comparison of targeted next-generation sequencing technologiesAndrea Maurizio Cabibbe, Kiarash Moghaddasi, Virginia Batignani, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|April 28, 2023
Comprehensive Drug Resistance Characterization of Pulmonary Tuberculosis in Algeria: Insights on <i>Mycobacterium tuberculosis</i> Strains by Whole-Genome SequencingDalila Benremila, Ferhat Djoudi, Alima Gharout-Sait, et al.
Research in Microbiology|March 19, 2021
Performance of the GenoType MTBDRsl V 2.0 for detecting second-line drugs resistance of Mycobacterium tuberculosis isolates in TunisiaImen Bouzouita, Henda Draoui, Andrea Maurizio Cabibbe, et al.
Emerging Infectious Diseases|February 22, 2019
Whole-Genome Sequencing of Drug-Resistant Mycobacterium tuberculosis Strains, Tunisia, 2012-2016Imen Bouzouita, Andrea Maurizio Cabibbe, Alberto Trovato, et al.
BMJ Global Health|November 5, 2025
Targeted next-generation sequencing for drug-resistant tuberculosis diagnosis: implementation considerations for bacterial load, regimen selection and diagnostic algorithm placementSophia B Georghiou, Nestani Tukvadze, Camilla Rodrigues, et al.
The Journal of Antimicrobial Chemotherapy|April 15, 2016
Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 systemElisa Schena, Lubov Nedialkova, Emanuele Borroni, et al.
The Lancet Regional Health. Europe|December 1, 2025
Diagnostic algorithms for tuberculosis in Europe: insights from the European Reference Laboratory Network for Tuberculosis (ERLTB-Net)Francesca Saluzzo, Andrea Maurizio Cabibbe, Richard Anthony, et al.
Scientific Reports|May 3, 2022
Whole genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates collected in the Czech Republic, 2005-2020Matúš Dohál, Věra Dvořáková, Miluše Šperková, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|January 10, 2022
Anti-tuberculosis drug resistance in Slovakia, 2018-2019: The first whole-genome epidemiological studyMatúš Dohál, Věra Dvořáková, Miluše Šperková, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Microbiology|February 23, 2023
Advantages of long- and short-reads sequencing for the hybrid investigation of the <i>Mycobacterium tuberculosis</i> genomeFederico Di Marco, Andrea Spitaleri, Simone Battaglia, et al.
Journal of Clinical Microbiology|September 6, 2024
Nanopore-based targeted sequencing test for direct tuberculosis identification, genotyping, and detection of drug resistance mutations: a side-by-side comparison of targeted next-generation sequencing technologiesAndrea Maurizio Cabibbe, Kiarash Moghaddasi, Virginia Batignani, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|April 28, 2023
Comprehensive Drug Resistance Characterization of Pulmonary Tuberculosis in Algeria: Insights on <i>Mycobacterium tuberculosis</i> Strains by Whole-Genome SequencingDalila Benremila, Ferhat Djoudi, Alima Gharout-Sait, et al.
Research in Microbiology|March 19, 2021
Performance of the GenoType MTBDRsl V 2.0 for detecting second-line drugs resistance of Mycobacterium tuberculosis isolates in TunisiaImen Bouzouita, Henda Draoui, Andrea Maurizio Cabibbe, et al.
Emerging Infectious Diseases|February 22, 2019
Whole-Genome Sequencing of Drug-Resistant Mycobacterium tuberculosis Strains, Tunisia, 2012-2016Imen Bouzouita, Andrea Maurizio Cabibbe, Alberto Trovato, et al.
BMJ Global Health|November 5, 2025
Targeted next-generation sequencing for drug-resistant tuberculosis diagnosis: implementation considerations for bacterial load, regimen selection and diagnostic algorithm placementSophia B Georghiou, Nestani Tukvadze, Camilla Rodrigues, et al.
The Journal of Antimicrobial Chemotherapy|April 15, 2016
Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 systemElisa Schena, Lubov Nedialkova, Emanuele Borroni, et al.
The Lancet Regional Health. Europe|December 1, 2025
Diagnostic algorithms for tuberculosis in Europe: insights from the European Reference Laboratory Network for Tuberculosis (ERLTB-Net)Francesca Saluzzo, Andrea Maurizio Cabibbe, Richard Anthony, et al.
Scientific Reports|May 3, 2022
Whole genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates collected in the Czech Republic, 2005-2020Matúš Dohál, Věra Dvořáková, Miluše Šperková, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|January 10, 2022
Anti-tuberculosis drug resistance in Slovakia, 2018-2019: The first whole-genome epidemiological studyMatúš Dohál, Věra Dvořáková, Miluše Šperková, et al.
Pageof 3